Mollie Mulheron, a 28-year-old cancer survivor from Padiham, Lancashire, is advocating for NHS support for fertility preservation following aggressive chemotherapy treatment. Her journey began when she was diagnosed with stage four blood cancer while traveling in the Galapagos Islands. This urgent health crisis meant she could not opt for fertility preservation before starting her lifesaving treatment.

Upon her return to the UK, doctors discovered a large tumor compressing her heart and left lung. Mollie underwent approximately 800 hours of chemotherapy over an intense 150-day period, ultimately emerging cancer-free. However, the aggressive nature of her cancer precluded any opportunity to freeze her eggs prior to treatment, a factor that could significantly impact her future ability to have children.

Now recovered, Mollie is confronting the NHS Lancashire and South Cumbria Integrated Care Board’s decision not to fund fertility preservation post-treatment. The rationale behind this decision is that she does not meet the board’s eligibility criteria. Naturally, this has provoked frustration for Mollie, who points out that funding is available for many patients undergoing chemotherapy.

Her advocacy highlights a “postcode lottery” in fertility preservation funding. While some areas may offer the service, others do not, leaving patients like her in limbo. In Leeds, where she initially received treatment, discussions about fertility preservation post-chemotherapy were on the table, but not once she moved back to Lancashire.

Mollie has initiated an online petition calling for consistent funding frameworks to support fertility preservation for young cancer survivors across the nation. She reveals that her ovarian reserve has drastically declined, suggesting a likelihood of early menopause, which intensifies the urgency of this issue for her and potentially many others.

This advocacy is supported by updated guidelines from the National Institute for Health and Care Excellence (NICE), which recommend that healthcare providers discuss fertility preservation with patients undergoing treatments that might impair fertility. Unfortunately, these guidelines lack enforcement, leading to inconsistent implementation across different NHS bodies.

Mollie’s campaign extends beyond personal advocacy; she hopes to reform policies and ensure equitable treatment for all cancer survivors facing similar fertility challenges. Her efforts include engaging with policymakers in Westminster, aiming to bridge the gap between existing guidance and actual practice.

A spokesperson for the NHS Lancashire and South Cumbria Integrated Care Board stated that while they are unable to discuss specific cases publicly, they are reviewing their clinical policies in collaboration with neighboring regions, with fertility-related services highlighted as a priority.

Photo by Nguyễn Hiệp on Unsplash